Lahore: Citi Pharma Ltd. has announced that it will hold a board meeting on October 29, 2025, to deliberate on the post-election composition of its Board of Directors and appoint key management positions. The meeting is scheduled to commence at 09:30 in Lahore.
The company has implemented the “Closed Period” from October 29, 2025, to October 29, 2025, in compliance with Clause 5.6.1.(d) of the Pakistan Stock Exchange (PSX) Regulations. During this time, no Director, CEO, or Executive is permitted to engage in any dealings involving the company’s shares, either directly or indirectly. According to information available from the Pakistan Stock Exchange (PSX), this measure is standard practice to ensure transparency and fairness in the market.
Furthermore, Citi Pharma Ltd. has communicated with the Certificate Holders of the Exchange regarding these developments, ensuring that all regulatory requirements are met.